Breaking News

Sterigenics Expands Forth Worth Facility

January 5, 2016

Adds gamma cell that will increase capacity by 30%

Sterigenics International is expanding its Forth Worth, TX location with a new gamma cell that will increase capacity by 30%. 
“We have committed more than $80 million in capital investments in the past year to support our customers’ growth strategies,” said Michael Mulhern, chief executive officer of Sterigenics. “In addition to our Fort Worth expansion, we tripled sterilization capacity at the Sterigenics West Memphis, Arkansas location; significantly expanded our Gurnee, Illinois irradiation facility and increased our global service capabilities with the acquisition of leading Latin American sterilization firm Companhia Brasileira de Esterilização (CBE).”
“The Fort Worth expansion is the direct result of increased regional demand for Sterigenics irradiation services,” said Philip Macnabb, President of Sterigenics International LLC.  “We are adding gamma processing capacity of up to 5 million cubic feet per year in Texas, with a product overlap system which will provide the capability to process numerous dose ranges and a wide variety of densities.”
Sterigenics Fort Worth provides routine gamma, GammaStat rapid processing, process validation and SteriPro laboratory testing. The expansion will be complete by 2Q17.

Related Contract Manufacturing:

Related Compliance:

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO